A carregar...

Biosimilars in India; Current Status and Future Perspectives

Many key biologics are scheduled to lose their patent by the year 2020, which will provide the opportunity to other biopharmaceutical companies to develop the similar biologics. Biosimilar or similar biologic used has increased in the recent year following the approval of the first biosimilar in ear...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Pharm Bioallied Sci
Main Authors: Meher, Bikash R., Balan, Sakthi, Mohanty, Rashmi R., Jena, Monalisa, Das, Smita
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6394151/
https://ncbi.nlm.nih.gov/pubmed/30906134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/jpbs.JPBS_167_18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!